Can we make smart choices between OLS and contaminated IV methods?
暂无分享,去创建一个
[1] Jeffrey A. Lieberman,et al. Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder , 2002 .
[2] J. Stock,et al. Retrospectives Who Invented Instrumental Variable Regression , 2003 .
[3] Charles E McCulloch,et al. Efficacy of Phototherapy for Newborns with Hyperbilirubinemia , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[4] J. Stock,et al. Instrumental Variables Regression with Weak Instruments , 1994 .
[5] D. Revicki,et al. Olanzapine versus Risperidone , 2000, PharmacoEconomics.
[6] David A. Jaeger,et al. Problems with Instrumental Variables Estimation when the Correlation between the Instruments and the Endogenous Explanatory Variable is Weak , 1995 .
[7] Paul J Rathouz,et al. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. , 2008, Journal of health economics.
[8] James H. Stock,et al. Who Invented Instrumental Variable Regression , 2003 .
[9] J. Lieberman,et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.
[10] Partha Deb,et al. When and how to use instrumental variables in palliative care research. , 2009, Journal of palliative medicine.
[11] Zhongyun Zhao,et al. Economic outcomes associated with olanzapine versus risperidone in the treatment of uncontrolled schizophrenia , 2004, Current medical research and opinion.
[12] Sebastian Schneeweiss,et al. Preference-Based Instrumental Variable Methods for the Estimation of Treatment Effects: Assessing Validity and Interpreting Results , 2007, The international journal of biostatistics.
[13] Christopher R. Taber,et al. Selection on Observed and Unobserved Variables: Assessing the Effectiveness of Catholic Schools , 2000, Journal of Political Economy.
[14] David J Vanness,et al. Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample size. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] Michael P. Murray. Avoiding Invalid Instruments and Coping with Weak Instruments , 2006 .